Report Detail
Global Diabetes Testing System Market Research Report 2022
- RnM4438570 |
- 11 May, 2022 |
- Global |
- 98 Pages |
- QYResearch |
- Medical Devices & Consumables
Summary:
Diabetes Testing Systems are the systems used at home or health care settings for monitoring the blood glucose levels in diabetic patients. Testing blood glucose level is the best way to understand diabetes and how different foods, medications, and other activities affect diabetes. Therefore, there is a need to keep a track of the blood glucose level in the body.
Industry Insights
Due to the COVID-19 pandemic, the global Diabetes Testing System market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Diabetes Testing System market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Diabetes Testing System landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Self-Monitoring Diabetes Testing Systems accounting for % of the Diabetes Testing System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Home Care segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Diabetes Testing System include Roche Holding AG, Abbott Laboratories, Sanofi S.A., ACON Laboratories, Nova Biomedical, Nipro Corporation, Braun Holding GmbH, DexCom and Medtronic Plc and etc. In terms of revenue, the global 3 largest players have a % market share of Diabetes Testing System in 2021.
This report focuses on Diabetes Testing System volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Diabetes Testing System market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Diabetes Testing System market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
Self-Monitoring Diabetes Testing Systems
Continuous Diabetes Testing Systems
Others
Segment by Application
Home Care
Hospitals
Clinics
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Roche Holding AG
Abbott Laboratories
Sanofi S.A.
ACON Laboratories
Nova Biomedical
Nipro Corporation
Braun Holding GmbH
DexCom
Medtronic Plc
ARKRAY
Frequently Asked Questions
Which product segment grabbed the largest share in the Diabetes Testing System market?
How is the competitive scenario of the Diabetes Testing System market?
Which are the key factors aiding the Diabetes Testing System market growth?
Which are the prominent players in the Diabetes Testing System market?
Which region holds the maximum share in the Diabetes Testing System market?
What will be the CAGR of the Diabetes Testing System market during the forecast period?
Which application segment emerged as the leading segment in the Diabetes Testing System market?
What key trends are likely to emerge in the Diabetes Testing System market in the coming years?
What will be the Diabetes Testing System market size by 2028?
Which company held the largest share in the Diabetes Testing System market?
Table of Contents
1 Diabetes Testing System Market Overview
- 1.1 Product Overview and Scope of Diabetes Testing System
- 1.2 Diabetes Testing System Segment by Type
- 1.2.1 Global Diabetes Testing System Sales Growth Rate Comparison by Type (2022-2028)
- 1.2.2 Self-Monitoring Diabetes Testing Systems
- 1.2.3 Continuous Diabetes Testing Systems
- 1.2.4 Others
- 1.3 Diabetes Testing System Segment by Application
- 1.3.1 Global Diabetes Testing System Sales Comparison by Application: (2022-2028)
- 1.3.2 Home Care
- 1.3.3 Hospitals
- 1.3.4 Clinics
- 1.3.5 Others
- 1.4 Global Diabetes Testing System Market Size Estimates and Forecasts
- 1.4.1 Global Diabetes Testing System Revenue 2017-2028
- 1.4.2 Global Diabetes Testing System Sales 2017-2028
- 1.4.3 Diabetes Testing System Market Size by Region: 2017 Versus 2021 Versus 2028
2 Diabetes Testing System Market Competition by Manufacturers
- 2.1 Global Diabetes Testing System Sales Market Share by Manufacturers (2017-2022)
- 2.2 Global Diabetes Testing System Revenue Market Share by Manufacturers (2017-2022)
- 2.3 Global Diabetes Testing System Average Price by Manufacturers (2017-2022)
- 2.4 Manufacturers Diabetes Testing System Manufacturing Sites, Area Served, Product Type
- 2.5 Diabetes Testing System Market Competitive Situation and Trends
- 2.5.1 Diabetes Testing System Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Diabetes Testing System Players Market Share by Revenue
- 2.5.3 Global Diabetes Testing System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Testing System Retrospective Market Scenario by Region
- 3.1 Global Diabetes Testing System Retrospective Market Scenario in Sales by Region: 2017-2022
- 3.2 Global Diabetes Testing System Retrospective Market Scenario in Revenue by Region: 2017-2022
- 3.3 North America Diabetes Testing System Market Facts & Figures by Country
- 3.3.1 North America Diabetes Testing System Sales by Country
- 3.3.2 North America Diabetes Testing System Revenue by Country
- 3.3.3 United States
- 3.3.4 Canada
- 3.4 Europe Diabetes Testing System Market Facts & Figures by Country
- 3.4.1 Europe Diabetes Testing System Sales by Country
- 3.4.2 Europe Diabetes Testing System Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Diabetes Testing System Market Facts & Figures by Region
- 3.5.1 Asia Pacific Diabetes Testing System Sales by Region
- 3.5.2 Asia Pacific Diabetes Testing System Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 China Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.6 Latin America Diabetes Testing System Market Facts & Figures by Country
- 3.6.1 Latin America Diabetes Testing System Sales by Country
- 3.6.2 Latin America Diabetes Testing System Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Diabetes Testing System Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Diabetes Testing System Sales by Country
- 3.7.2 Middle East and Africa Diabetes Testing System Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 UAE
4 Global Diabetes Testing System Historic Market Analysis by Type
- 4.1 Global Diabetes Testing System Sales Market Share by Type (2017-2022)
- 4.2 Global Diabetes Testing System Revenue Market Share by Type (2017-2022)
- 4.3 Global Diabetes Testing System Price by Type (2017-2022)
5 Global Diabetes Testing System Historic Market Analysis by Application
- 5.1 Global Diabetes Testing System Sales Market Share by Application (2017-2022)
- 5.2 Global Diabetes Testing System Revenue Market Share by Application (2017-2022)
- 5.3 Global Diabetes Testing System Price by Application (2017-2022)
6 Key Companies Profiled
- 6.1 Roche Holding AG
- 6.1.1 Roche Holding AG Corporation Information
- 6.1.2 Roche Holding AG Description and Business Overview
- 6.1.3 Roche Holding AG Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.1.4 Roche Holding AG Diabetes Testing System Product Portfolio
- 6.1.5 Roche Holding AG Recent Developments/Updates
- 6.2 Abbott Laboratories
- 6.2.1 Abbott Laboratories Corporation Information
- 6.2.2 Abbott Laboratories Description and Business Overview
- 6.2.3 Abbott Laboratories Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.2.4 Abbott Laboratories Diabetes Testing System Product Portfolio
- 6.2.5 Abbott Laboratories Recent Developments/Updates
- 6.3 Sanofi S.A.
- 6.3.1 Sanofi S.A. Corporation Information
- 6.3.2 Sanofi S.A. Description and Business Overview
- 6.3.3 Sanofi S.A. Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.3.4 Sanofi S.A. Diabetes Testing System Product Portfolio
- 6.3.5 Sanofi S.A. Recent Developments/Updates
- 6.4 ACON Laboratories
- 6.4.1 ACON Laboratories Corporation Information
- 6.4.2 ACON Laboratories Description and Business Overview
- 6.4.3 ACON Laboratories Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.4.4 ACON Laboratories Diabetes Testing System Product Portfolio
- 6.4.5 ACON Laboratories Recent Developments/Updates
- 6.5 Nova Biomedical
- 6.5.1 Nova Biomedical Corporation Information
- 6.5.2 Nova Biomedical Description and Business Overview
- 6.5.3 Nova Biomedical Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.5.4 Nova Biomedical Diabetes Testing System Product Portfolio
- 6.5.5 Nova Biomedical Recent Developments/Updates
- 6.6 Nipro Corporation
- 6.6.1 Nipro Corporation Corporation Information
- 6.6.2 Nipro Corporation Description and Business Overview
- 6.6.3 Nipro Corporation Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.6.4 Nipro Corporation Diabetes Testing System Product Portfolio
- 6.6.5 Nipro Corporation Recent Developments/Updates
- 6.7 Braun Holding GmbH
- 6.6.1 Braun Holding GmbH Corporation Information
- 6.6.2 Braun Holding GmbH Description and Business Overview
- 6.6.3 Braun Holding GmbH Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.4.4 Braun Holding GmbH Diabetes Testing System Product Portfolio
- 6.7.5 Braun Holding GmbH Recent Developments/Updates
- 6.8 DexCom
- 6.8.1 DexCom Corporation Information
- 6.8.2 DexCom Description and Business Overview
- 6.8.3 DexCom Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.8.4 DexCom Diabetes Testing System Product Portfolio
- 6.8.5 DexCom Recent Developments/Updates
- 6.9 Medtronic Plc
- 6.9.1 Medtronic Plc Corporation Information
- 6.9.2 Medtronic Plc Description and Business Overview
- 6.9.3 Medtronic Plc Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.9.4 Medtronic Plc Diabetes Testing System Product Portfolio
- 6.9.5 Medtronic Plc Recent Developments/Updates
- 6.10 ARKRAY
- 6.10.1 ARKRAY Corporation Information
- 6.10.2 ARKRAY Description and Business Overview
- 6.10.3 ARKRAY Diabetes Testing System Sales, Revenue and Gross Margin (2017-2022)
- 6.10.4 ARKRAY Diabetes Testing System Product Portfolio
- 6.10.5 ARKRAY Recent Developments/Updates
7 Diabetes Testing System Manufacturing Cost Analysis
- 7.1 Diabetes Testing System Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Diabetes Testing System
- 7.4 Diabetes Testing System Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Diabetes Testing System Distributors List
- 8.3 Diabetes Testing System Customers
9 Diabetes Testing System Market Dynamics
- 9.1 Diabetes Testing System Industry Trends
- 9.2 Diabetes Testing System Market Drivers
- 9.3 Diabetes Testing System Market Challenges
- 9.4 Diabetes Testing System Market Restraints
10 Global Market Forecast
- 10.1 Diabetes Testing System Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Diabetes Testing System by Type (2023-2028)
- 10.1.2 Global Forecasted Revenue of Diabetes Testing System by Type (2023-2028)
- 10.2 Diabetes Testing System Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Diabetes Testing System by Application (2023-2028)
- 10.2.2 Global Forecasted Revenue of Diabetes Testing System by Application (2023-2028)
- 10.3 Diabetes Testing System Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Diabetes Testing System by Region (2023-2028)
- 10.3.2 Global Forecasted Revenue of Diabetes Testing System by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
Summary:
Get latest Market Research Reports on Diabetes Testing System. Industry analysis & Market Report on Diabetes Testing System is a syndicated market report, published as Global Diabetes Testing System Market Research Report 2022. It is complete Research Study and Industry Analysis of Diabetes Testing System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
